Adjustment for the measurement error in evaluating biomarker performances at baseline for future survival outcomes: Time-dependent receiver operating characteristic curve within a joint modelling framework

R. Kolamunnage-Dona, A. Kamarudin
{"title":"Adjustment for the measurement error in evaluating biomarker performances at baseline for future survival outcomes: Time-dependent receiver operating characteristic curve within a joint modelling framework","authors":"R. Kolamunnage-Dona, A. Kamarudin","doi":"10.1177/2632084320972257","DOIUrl":null,"url":null,"abstract":"The performance of a biomarker is defined by how well the biomarker is capable to distinguish between healthy and diseased individuals. This assessment is usually based on the baseline value of the biomarker; the value at the earliest time point of the patient follow-up, and quantified by ROC (receiver operating characteristic) curve analysis. However, the observed baseline value is often subjected to measurement error due to imperfect laboratory conditions and limited machine precision. Failing to adjust for measurement error may underestimate the true performance of the biomarker, and in a direct comparison, useful biomarkers could be overlooked. We develop a novel approach to account for measurement error when calculating the performance of the baseline biomarker value for future survival outcomes. We adopt a joint longitudinal and survival data modelling formulation and use the available longitudinally repeated values of the biomarker to make adjustment of the measurement error in time-dependent ROC curve analysis. Our simulation study shows that the proposed measurement error-adjusted estimator is more efficient for evaluating the performance of the biomarker than estimators ignoring the measurement error. The proposed method is illustrated using Mayo Clinic primary biliary cirrhosis (PBC) study.","PeriodicalId":74683,"journal":{"name":"Research methods in medicine & health sciences","volume":"2 1","pages":"51 - 60"},"PeriodicalIF":0.0000,"publicationDate":"2020-11-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1177/2632084320972257","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Research methods in medicine & health sciences","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/2632084320972257","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

The performance of a biomarker is defined by how well the biomarker is capable to distinguish between healthy and diseased individuals. This assessment is usually based on the baseline value of the biomarker; the value at the earliest time point of the patient follow-up, and quantified by ROC (receiver operating characteristic) curve analysis. However, the observed baseline value is often subjected to measurement error due to imperfect laboratory conditions and limited machine precision. Failing to adjust for measurement error may underestimate the true performance of the biomarker, and in a direct comparison, useful biomarkers could be overlooked. We develop a novel approach to account for measurement error when calculating the performance of the baseline biomarker value for future survival outcomes. We adopt a joint longitudinal and survival data modelling formulation and use the available longitudinally repeated values of the biomarker to make adjustment of the measurement error in time-dependent ROC curve analysis. Our simulation study shows that the proposed measurement error-adjusted estimator is more efficient for evaluating the performance of the biomarker than estimators ignoring the measurement error. The proposed method is illustrated using Mayo Clinic primary biliary cirrhosis (PBC) study.
对未来生存结果基线生物标志物性能评估测量误差的调整:联合建模框架内随时间变化的受试者工作特征曲线
生物标志物的性能是由生物标志物区分健康和患病个体的能力来定义的。这种评估通常基于生物标志物的基线值;患者随访最早时间点的值,用ROC(受试者工作特征)曲线分析进行量化。然而,由于实验室条件的不完善和机器精度的限制,观察到的基线值经常受到测量误差的影响。未能调整测量误差可能会低估生物标志物的真实性能,并且在直接比较中,有用的生物标志物可能会被忽略。我们开发了一种新的方法来解释在计算基线生物标志物值对未来生存结果的表现时的测量误差。我们采用纵向和生存数据联合建模公式,并利用生物标志物的纵向重复值对随时间变化的ROC曲线分析中的测量误差进行调整。我们的仿真研究表明,所提出的测量误差调整估计比忽略测量误差的估计更有效地评估生物标志物的性能。梅奥诊所原发性胆汁性肝硬化(PBC)研究说明了该方法。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信